Programme
5 May 2025
12:30 to 14:00 – Arrival and optional open lunch
Session 1 – Brussels HQ, In-person (14:00 – 18:00)
Career and research opportunities at EORTC & EORTC Taskforces
- Introduction: about the program, its agenda, and learning objectives ( P. Szturz)
- Wrap-up Y-ECI community (J. Lehmann, J. Zerdes)
- Scientific strategy of EORTC – what EORTC does and what it does not do – interactive discussion, Q&A (B. Besse)
- EORTC Taskforces – brief topic teasers
- General introduction (B. Besse)
- MRD (B. Besse)
- Radioligands (J. Silva)
- ADC (A. Joaquim)
- Older adults (S. Marreaud)
- Rare cancers (D. Lacombe)
- Break
- Mc Kinsey session (Mc Kinsey)
19:00 – Walking Dinner
6 May 2025
Session 1 – Brussels HQ, In-person (9:00 – 15:00)
Growth and development
- Career growth and leadership – (McKinsey)
12:00 to 13:00 – Lunch
- Career growth and leadership – (McKinsey)
20 May 2025
Session 2 – Virtual
Core outcome sets and Quality of Life
- Introduction (J. Lehmann)
- Core Outcome Sets (S. McLennan)
- Patient-Reported Outcomes in Clinical Trials (J. Giesinger)
- Patient-Reported Outcomes in Clinical Practice (M. Van Hemelrijck)
- Wrap up & teaser for the next session (J. Lehmann)
10 June 2025
Session 3 – Virtual
Recap session, Q&A and McKinsey update
- Introduction (L. Zerdes)
- Mc Kinsey update (TBC)
- Minimal Residual Disease (B. Besse)
- Wrap up & teaser for the next session (L. Zerdes)
24 June 2025
Session 4 – Virtual – Not eligible for CME accreditation
Partnership with Industry and Academia and Focus on EORTC Taskforces (Antibody-Drug Conjugates)
- Introduction (D. Lacombe)
- EORTC principles of partnerships with industry (V. Golfinopoulos)
- Commercial perspectives (P. Therasse, M. Zaiac)
- Academic perspectives (J-P. Machiels)
- Antibody-drug conjugates (M. Ignatiadis)
- Wrap up & teaser for the next session (D. Lacombe)
9 September 2025
Session 5 – Virtual
Statistics
- Statistics (S. Litière, J. Bogaerts, M. Mauer)
- Recap: Q&A (Steering Committee)
23 September 2025
Session 6 – Virtual
Special Lecture: ECIs meet EORTC presidents and Focus on EORTC Taskforces (Rare Cancers)
- Introduction (D. Lacombe)
- ECIs Meet EORTC Presidents: Interactive Live Discussion (W. Van der Graaf, B. Tombal)
- Rare Cancers (W. Van der Graaf)
- Wrap up & teaser for the next session (D. Lacombe)
7 October 2025
Session 7 – Virtual
Pragmatic trials, Independent clinical research in Europe and Focus on EORTC Taskforces (Older adults)
- Introduction (J. Lehmann)
- Treatment optimisation as a concept (D. Lacombe)
- Pragmatic trials as a way to address treatment optimisation (F. Borges)
- Older adults (P. Bossi or L. Dal Lago)
- Wrap up & teaser for the next session (J. Lehmann)
27 October 2025
Session 8 – Virtual
ECIs meet editor of EJC, European Policies, Common Sense Oncology, and Focus on EORTC Taskforces (Radioligands)
- Introduction (P. Szturz)
- Meet the EJC Publisher (A. Murphy)
- European policies (R. Sullivan)
- Common Sense Oncology (C. Booth)
- Radioligands (M. Preusser or C. Deroose)
- Wrap up & teaser for the next session (P. Szturz)
25 November 2025
12:30 to 14:00 – Arrival and optional open lunch
Session 9 – Brussels HQ, In-person (14:00 – 18:00)
Project ideas and Statistics
- Introduction ( J. Lehmann)
- Statistics or critical appraisal of 1-2 publications – preceded by a homework (C. Coens)
- Presentation of (selected) ECI project proposals (B. Besse or M. Weller – Virtually, V. Golfinopoulos & S. Litiere & J. Bogaerts
– In person)
19:00 – Dinner
26 November 2025
Session 9 – Brussels HQ, In-person (8:30 – 15:00)
Setting up for success – getting to know the EORTC
- Introduction ( P. Szturz)
- Interaction with EORTC HQ staff (V. Golfinopoulos)
- Regulatory considerations (S. Kromar)
- Regulatory science in 2025: an update by the EMA (R. Herold)
- Fundraising (A. Koulentaki)
- Break
- Testimonial of a successful EORTC clinical trial researcher (M. van den Bent)
- Patient involvement in EORTC trials and projects, patient representative (I. Shakhnenko, R. Wilson – potentially Virtual)
- Lunch, group photo
- Presentation of (selected) ECI project proposals (part II or follow-up) Closing session, feedback from the attendees
